S.I. No. 135/2012 - Clotting Factor Concentrates and Other Biological Products Act 2012 (Commencement) Order 2012.
Statutory Text (3 Articles)
1. This Order may be cited as the Clotting Factor Concentrates and Other Biological Products Act 2012 (Commencement) Order 2012.
2. 30 April 2012 is appointed as the day on which the
Clotting Factor Concentrates and Other Biological Products Act 2012
(No. 8 of 2012) comes into operation.
GIVEN under my Official Seal,
17 April 2012.
JAMES REILLY,
Minister for Health.
EXPLANATORY NOTE
(This note is not part of the Instrument and does not purport to be a legal interpretation)
This Order provides for the commencement of the
Clotting Factor Concentrates and Other Biological Products Act 2012
(No. 8 of 2012).
This Act transfers responsibility for the procurement of the national stock of clotting factor concentrates and other biological medicinal products, used in the treatment of haemophilia and other coagulation, congenital or acquired disorders, from the Irish Blood Transfusion Service to St James’s Hospital.
Notice of the making of this Statutory Instrument was published in
“Iris Oifigiúil” of
1
st May
, 2012.
I, JAMES REILLY, Minister for Health, in exercise of the powers conferred on me by
section 4
(2) of the
Clotting Factor Concentrates and Other Biological Products Act 2012
(No. 8 of 2012), hereby order as follows